Cd19-positive B-cell Acute Lymphoblastic Leukemia

• CLINICAL_TRIALS research · 2026-04-07
  Clinical Trial Update: Recombinant Erwinia Asparaginase and Venetoclax in Combination With Blinatumomab for the Treatment of Relapsed or Refractory CD19 Positive B-cell Acute Lymphoblastic Leukemia [Phase 1]

  A Phase 1 clinical trial evaluating a triple combination of recombinant Erwinia asparaginase, venetoclax, and blinatumomab for relapsed or r…

• CLINICAL_TRIALS trial_result · 2017-01-20
  Clinical Trial Update: A Phase I Study Evaluating Safety and Efficacy of C-CAR011 Treatment in Adult Subjects With r/r CD19+B-ALL [Phase 1]

  Phase I clinical trial evaluating the safety and initial efficacy of C-CAR011, a CD19-targeted CAR-T therapy, in adults with relapsed or ref…